Home > Market > Market Stats >  Dr Reddys Laboratories

Company Summary

DR REDDYS LABORATORIES SUMMARY

Dr Reddys Laboratories is trading 0.06% lower at Rs 4371.30 as compared to its last closing price. Dr Reddys Laboratories has been trading in the price range of 4375.8 & 4338.0. Dr Reddys Laboratories has given -8.71% in this year & 1.76% in the last 5 days.

 

Dr Reddys Laboratories has TTM P/E ratio 23.14 as compared to the sector P/E of 27.15. There are 39 analysts who have initiated coverage on Dr Reddys Laboratories. There are 16 analysts who have given it a strong buy rating & 16 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

 

The company posted a net profit of 1114.2 Crores in its last quarter.

 

Listed peers of Dr Reddys Laboratories include Cipla (0.28%), Divis Laboratories (-0.18%), Dr Reddys Laboratories (-0.06%) etc.

FAQs about Dr Reddys Laboratories

Dr Reddys Laboratories is trading at 4371.30 as on 7 Dec, 2022 11:41:39 AM. This is -0.06% lower as compared to its previous closing price of 4374
The market capitalization of Dr Reddys Laboratories is 74381.13 Cr as on 7 Dec, 2022 11:41:39 AM.
The average broker rating on Dr Reddys Laboratories is Buy. The breakup of analyst rating is given below -
  • 1 analysts have given a strong sell rating
  • 1 analysts have given a sell rating
  • 5 analysts have given a hold rating
  • 16 analysts have given a buy rating
  • 16 analysts have given a strong buy rating
The 52 wk high for Dr Reddys Laboratories is 4930.0 whereas the 52 wk low is 3655.0
Dr Reddys Laboratories can be analyzed on the following key metrics -
  • TTM P/E: 23.14
  • Sector P/E: 27.15
  • Dividend Yield: 0.67%
  • D/E ratio: -
Dr Reddys Laboratories reported a net profit of 2182.5 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout